S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave

Evolent Health (EVH) Stock Price, News & Analysis

$29.51
-0.11 (-0.37%)
(As of 04/19/2024 ET)
Today's Range
$29.06
$29.73
50-Day Range
$29.51
$34.74
52-Week Range
$23.33
$36.70
Volume
734,826 shs
Average Volume
710,573 shs
Market Capitalization
$3.41 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.00

Evolent Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.91 Rating Score
Upside/​Downside
45.7% Upside
$43.00 Price Target
Short Interest
Bearish
9.19% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.18mentions of Evolent Health in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
58.62%
From $0.87 to $1.38 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.51 out of 5 stars

Computer And Technology Sector

481st out of 581 stocks

Management Services Industry

5th out of 5 stocks

EVH stock logo

About Evolent Health Stock (NYSE:EVH)

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

EVH Stock Price History

EVH Stock News Headlines

Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Evolent Health, Inc. (EVH)
EVH Apr 2024 27.500 put
Navigating 4 Analyst Ratings For Evolent Health
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Analyst Scoreboard: 4 Ratings For Evolent Health
Barclays Reaffirms Their Buy Rating on Evolent Health (EVH)
Evolent Health Inc (EVH)
Evolent Health Stock (NYSE:EVH) Insider Trades
EVH Evolent Health, Inc.
See More Headlines
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/20/2024
Next Earnings (Confirmed)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
N/A
Employees
4,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$43.00
High Stock Price Target
$52.00
Low Stock Price Target
$34.00
Potential Upside/Downside
+45.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.91
Research Coverage
11 Analysts

Profitability

Net Income
$-113,040,000.00
Pretax Margin
-10.31%

Debt

Sales & Book Value

Annual Sales
$1.96 billion
Cash Flow
$1.78 per share
Book Value
$9.38 per share

Miscellaneous

Free Float
111,621,000
Market Cap
$3.41 billion
Optionable
Optionable
Beta
1.53
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Seth Barrie Blackley (Age 45)
    Co-Founder, CEO & Director
    Comp: $1.79M
  • Mr. Dan McCarthy (Age 39)
    CEO of New Century Health & President
    Comp: $1.29M
  • Mr. John Paul JohnsonMr. John Paul Johnson (Age 40)
    Chief Financial Officer
    Comp: $994.22k
  • Mr. Jonathan David Weinberg J.D. (Age 56)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $696.07k
  • Ms. Emily Rafferty (Age 41)
    Chief Operating Officer
  • Mr. Aammaad Shams (Age 40)
    Chief Accounting Officer
    Comp: $341.78k
  • Mr. Robert Cruz
    Chief Technology Officer
  • Ms. Jessica White
    Chief Information Officer
  • Mr. Seth R. Frank
    Vice President of Investor Relations
  • Ms. Kali Beyah
    Chief People & Brand Officer

EVH Stock Analysis - Frequently Asked Questions

Should I buy or sell Evolent Health stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVH shares.
View EVH analyst ratings
or view top-rated stocks.

What is Evolent Health's stock price target for 2024?

11 equities research analysts have issued 1-year price objectives for Evolent Health's stock. Their EVH share price targets range from $34.00 to $52.00. On average, they expect the company's stock price to reach $43.00 in the next year. This suggests a possible upside of 45.7% from the stock's current price.
View analysts price targets for EVH
or view top-rated stocks among Wall Street analysts.

How have EVH shares performed in 2024?

Evolent Health's stock was trading at $33.03 at the beginning of the year. Since then, EVH shares have decreased by 10.7% and is now trading at $29.51.
View the best growth stocks for 2024 here
.

When is Evolent Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our EVH earnings forecast
.

How can I listen to Evolent Health's earnings call?

Evolent Health will be holding an earnings conference call on Thursday, May 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) released its earnings results on Thursday, February, 22nd. The technology company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.02 by $0.13. The technology company had revenue of $556.06 million for the quarter, compared to analyst estimates of $541.87 million. Evolent Health had a positive trailing twelve-month return on equity of 6.60% and a negative net margin of 5.76%.

What ETFs hold Evolent Health's stock?
What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health issued an update on its FY 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.3 billion.

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Evolent Health own?
When did Evolent Health IPO?

Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by many different retail and institutional investors. Top institutional investors include Hodges Capital Management Inc. (0.41%), Salem Investment Counselors Inc. (0.10%), ERn Financial LLC (0.05%), WoodTrust Financial Corp (0.04%), First Dallas Securities Inc. (0.01%) and Banque Cantonale Vaudoise (0.00%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends
.

How do I buy shares of Evolent Health?

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:EVH) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners